Summary
This prediction ended on 12.09.12 with a price of €127.68. With a performance of 8.66%, the BUY prediction by melinda for Carmat closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Carmat | -10.154% | -10.154% | -65.848% | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
According to melinda what are the pros and cons of Carmat for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Carmat diskutieren
künstliches Herz
CARMAT ist die Medizintechnik Start-up, wenn das Herz voll implantierbaren Herzunterstützungssystem oder eine Transplantation fehlgeschlagen oder nicht möglich sind (wie auf seine Dreharbeiten Fenster)
(Vom Mitglied beendet)